International Biotechnology Trust’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-46,000
Closed -$464K 66
2022
Q4
$464K Sell
46,000
-75,000
-62% -$756K 0.14% 59
2022
Q3
$2.71M Buy
121,000
+117,083
+2,989% +$2.62M 0.87% 35
2022
Q2
$158K Sell
3,917
-24,083
-86% -$971K 1.65% 20
2022
Q1
$5.64M Hold
28,000
1.27% 26
2021
Q4
$1.64M Hold
28,000
0.36% 47
2021
Q3
$1.66M Buy
+28,000
New +$1.66M 0.4% 44